Renalytix Plc - ADR
RNLX
Get informed when a big investor buys or sells
+ FollowMarket Cap$22.55M
Close$
$-0.83
499% downside
Current Fair Value
499% downsideOvervalued by 499% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $22.55 Million |
|---|---|
| Enterprise Value | $29.89 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.62 |
| Beta | 2.1 |
| Outstanding Shares | 52,848,700 |
Return
| Return on Equity | 247.64% |
|---|---|
| Return on Assets | -584.69% |
| Return on Invested Capital | 312.43% |
Valuation & Multiples
| P/E Ratio | -0.33 |
|---|---|
| PEG | 0.63 |
| Price to Sales | - |
| Price to Book Ratio | -0.21 |
| Enterprise Value to Revenue | 12.71 |
| Enterprise Value to EBIT | -1.33 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.28 |
| Debt to Equity | -0.73 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About RenX Enterprises Corp.
6 employees
CEO: David Villarreal Jr. RenX Enterprises Corp. provides real estate development services. It focuses on the development of sites using purpose built, prefabricated modules built from both wood & steel, sourced from one of Safe & Green Holdings factories and ope...